Evaluation of biological features of cord blood units in different Taiwan ethnics

Acta Paediatrica Taiwanica

Volumn 48, Issue 2, 2007, Pages 57-61

  Jan, Rong Hwa ^a   Wen, Shu Hui ^b   Shih, Wen Lin ^c   Chang, Yu Hsun ^a   Chen, Shu Huey ^a,d  

^a Department of Pediatrics   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c Buddhist Tzu Chi Stem Cells Center   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

CD34+; Cord blood; Ethnic

Indexed keywords

HEMOGLOBIN;

ANALYSIS OF VARIANCE; ARTICLE; BIOLOGICAL TRAIT; CD34 SELECTION; CESAREAN SECTION; CONTROLLED STUDY; DEMOGRAPHY; ERYTHROCYTE; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; NEWBORN; TAIWAN; UMBILICAL CORD BLOOD; UNIVARIATE ANALYSIS; VAGINAL DELIVERY;

ANTIGENS, CD34; ERYTHROCYTE COUNT; FEMALE; FETAL BLOOD; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; MALE; TAIWAN;

EID: 34447260062     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90:4665-78.
2. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28:1197-205.
3. Hows JM, Bradley BA, Marsh JC, et al. Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet 1992; 340:73-6.
4. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989; 86:3828-32.
5. Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A 1992; 89:4109-13.
6. Qian JX, Lee SM, Suen Y, et al. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997; 90:3106-17.
7. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339:1565-77.
8. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344:1815-22.
9. Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96:2703-11.
10. Moretta A, Maccario R, Fagioli F, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29:371-9.
11. Jones J, Stevens CE, Rubinstein P, Robertazzi RR, Kerr A, Cabbad MF. Obstetric predictors of placental/umbilical cord blood volume for transplantation. Am J Obstet Gynecol 2003; 188:503-9.
12. Askari S, Miller J, Chrysler G, McCullogh J. Impact of donor-and-collection-related variables on product quality in ex utero cord blood banking. Transfusion 2005; 45:189-94.
13. Sparrow RL, Cauchi JA and Ramadi LT, et al. Influence of mode of birth and collection on WBC yields of umbilical cord blood units. Transfusion 2002; 42:210.
14. Solves P, Perales A and Mirabet V, etal. Optimizing donor selection in a cord blood bank, Eur J Haematol. 2004; 72:107.
15. Aroviita P, Teramo K, Hiilesmaa V, Kekomaki R. Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion 2005; 45:613-21.
16. Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 1999; 53:51-64.
17. McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner J. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion 2005; 45:832-41.
18. Ballen K, Broxmeyer HE, McCullough J, et al. Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001; 7:635-45.
19. Wanger JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100:1611-8.
20. Styczynski J, Cheung YK, Garvin J, et al. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2004; 34:129-36.
21. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32:397-407.
22. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996; 87:1-13.
23. Cairo MS, Wagner EL, Fraser J, et al. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weigh, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion 2005; 45:856-66.
24. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1:1017-23.
25. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003; 101:5061-7.
26. Stewart SL, Swallen KC, Glaser SL, et al. Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999; 149:1063-71.
27. Kaplan JB and Bennett T, Use of race and ethnicity in biomedical publication. JAMA 2003; 289:2709-16.